DeVuono MV et al. |
Conditioned gaping produced by high dose Δ-tetrahydracannabinol: Dysregulation of the hypothalamic endocannabinoid system. |
2018 |
Neuropharmacology |
pmid:30195587
|
Atwood BK et al. |
CBâ‚‚ cannabinoid receptors inhibit synaptic transmission when expressed in cultured autaptic neurons. |
2012 |
Neuropharmacology |
pmid:22579668
|
Walentiny DM et al. |
Phenotypic assessment of THC discriminative stimulus properties in fatty acid amide hydrolase knockout and wildtype mice. |
2015 |
Neuropharmacology |
pmid:25698527
|
Kortleven C et al. |
Neurotensin inhibits glutamate-mediated synaptic inputs onto ventral tegmental area dopamine neurons through the release of the endocannabinoid 2-AG. |
2012 |
Neuropharmacology |
pmid:22884466
|
Nader J et al. |
Prior stimulation of the endocannabinoid system prevents methamphetamine-induced dopaminergic neurotoxicity in the striatum through activation of CB2 receptors. |
2014 |
Neuropharmacology |
pmid:24709540
|
Pasquarelli N et al. |
Comparative biochemical characterization of the monoacylglycerol lipase inhibitor KML29 in brain, spinal cord, liver, spleen, fat and muscle tissue. |
2015 |
Neuropharmacology |
pmid:25497453
|
Morena M et al. |
Emotional arousal state influences the ability of amygdalar endocannabinoid signaling to modulate anxiety. |
2016 |
Neuropharmacology |
pmid:27553121
|
Desroches J et al. |
Endocannabinoids decrease neuropathic pain-related behavior in mice through the activation of one or both peripheral CBâ‚ and CBâ‚‚ receptors. |
2014 |
Neuropharmacology |
pmid:24148808
|
Morgan NH et al. |
Functional CB2 type cannabinoid receptors at CNS synapses. |
2009 |
Neuropharmacology |
pmid:19616018
|
Wilkerson JL et al. |
The endocannabinoid hydrolysis inhibitor SA-57: Intrinsic antinociceptive effects, augmented morphine-induced antinociception, and attenuated heroin seeking behavior in mice. |
2017 |
Neuropharmacology |
pmid:27890602
|
Placzek EA et al. |
Membrane microdomains and metabolic pathways that define anandamide and 2-arachidonyl glycerol biosynthesis and breakdown. |
2008 |
Neuropharmacology |
pmid:18760289
|
Best AR and Regehr WG |
Identification of the synthetic pathway producing the endocannabinoid that mediates the bulk of retrograde signaling in the brain. |
2010 |
Neuron |
pmid:20159441
|
Oleson EB et al. |
Endocannabinoids shape accumbal encoding of cue-motivated behavior via CB1 receptor activation in the ventral tegmentum. |
2012 |
Neuron |
pmid:22284189
|
Safo PK and Regehr WG |
Endocannabinoids control the induction of cerebellar LTD. |
2005 |
Neuron |
pmid:16301180
|
Gantz SC and Bean BP |
Cell-Autonomous Excitation of Midbrain Dopamine Neurons by Endocannabinoid-Dependent Lipid Signaling. |
2017 |
Neuron |
pmid:28262417
|
Duan Y et al. |
Inhibition of [3H]batrachotoxinin A-20alpha-benzoate binding to sodium channels and sodium channel function by endocannabinoids. |
2008 |
Neurochem. Int. |
pmid:17888543
|
Bardell TK and Barker EL |
Activation of TRPC6 channels promotes endocannabinoid biosynthesis in neuronal CAD cells. |
2010 |
Neurochem. Int. |
pmid:20466028
|
Sang N et al. |
Anandamide potentiation of miniature spontaneous excitatory synaptic transmission is mediated via IP3 pathway. |
2010 |
Neurochem. Int. |
pmid:20064571
|
Melis M et al. |
Protective activation of the endocannabinoid system during ischemia in dopamine neurons. |
2006 |
Neurobiol. Dis. |
pmid:16762556
|
Cabranes A et al. |
Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis. |
2005 |
Neurobiol. Dis. |
pmid:16242629
|